While we have shown that endothelial nitric oxide synthase (eNOS)-derived NO down regulates mitochondrial oxygen consumption during early reperfusion, its effects on inducible NOS (iNOS) induction and myocardial injury during late reperfusion is unknown. Wild-type (WT) and eNOS -/-mice were subjected to 30 min of coronary ligation followed by reperfusion.
INTRODUCTION
Nitric oxide (NO) is an important modulator of cardiac performance and left ventricular remodeling after myocardial infarction. In the setting of ischemic preconditioning, there is evidence that endothelial nitric oxide synthase (eNOS) -derived NO is important for the acute window of protection as well as the subsequent induction of inducible NOS (iNOS), triggering the delayed window of protection (4) . However, there has been considerable controversy regarding the effect of eNOS and eNOS-derived NO on myocardial ischemia/reperfusion injury.
In eNOS knockout mice (eNOS -/-), some studies have shown protection, while others have reported increased cardiac injury (6, 10, 14, 17, 24, 25) . Sharp, et al (24) reported that different eNOS -/-mouse strains responded differently to myocardial reperfusion injury, and that the protection seen in UNC eNOS -/-mice was due to compensatory increase in constitutive iNOS expression, however, they only measured mRNA levels not protein expression. A subsequent study did not find a compensatory increase of basal eNOS expression in iNOS -/-mice, and mice lacking iNOS had better preserved cardiac function and tended to have less severe chamber dilatation post-MI (18) . Thus, questions remain regarding the interrelationship of eNOS and iNOS expression as well as the role of eNOS in the process of iNOS induction in the normal and postischemic heart. Furthermore, the role of iNOS itself in the pathogenesis of postischemic injury remains unclear.
iNOS is thought to play the dominant role in NO production during the late phase of myocardial reperfusion. iNOS is prone to form superoxide and peroxynitrite and can induce cytotoxicity and cellular injury (32, 34) . Maximum induction of iNOS activity has been noted 48 to 72 hr after reperfusion (31) . Myocardial performance has been shown to be improved and infarct size reduced by continuous iNOS inhibition during 48 hr of reperfusion in rabbits (31) . A significant increase in survival and improved cardiac function was found after myocardial infarction in iNOS -/-mice (5). These observations suggest that the expression of iNOS contributes to abnormal function and cellular injury in postischemic myocardium. However, using iNOS -/-mice, Zingarelli, et al (36) found an exacerbation of myocardial injury 60 min after reperfusion, and Jones, et al (15) reported no alteration of myocardial injury 24 hr after reperfusion. Thus, the consequences of iNOS induction in the postischemic heart remain controversial.
It has been suggested that low doses of NO appear to be beneficial, but high doses harmful to postischemic myocardium (16). There is evidence that expression of one NOS isoform may be altered following deletion of another NOS isoform (17, 18) . To date, the role of eNOS in the induction of iNOS in postischemic myocardium and its subsequent role in postischemic injury are not well understood, especially in the late period of reperfusion. We have recently shown that eNOS-derived NO markedly suppresses in vivo myocardial O 2 consumption in the early period of reperfusion through modulation of mitochondrial respiration (35) . In this study, we tested the hypothesis that eNOS deletion alters iNOS expression and exerts a critical influence on myocardial injury at 48 hr reperfusion. Our results indicate that deletion of eNOS decreases the induction of iNOS and this prevents chronic NO-mediated inhibition of mitochondrial respiration. 
MATERIALS AND METHODS

Animals
In Vivo Ischemia/Reperfusion Mouse Model
The in vivo ischemia/reperfusion mouse model was performed by a technique similar to that previously described (35) . Mice were anesthetized with ketamine (55 mg/kg) plus xylazine (15 mg/kg). Atropine (0.05 mg SC) was administered to reduce airway excretion. Animals were intubated and ventilated with room air (tidal volume 250 µl, 100 breaths/min) using a mouse respirator (Harvard Apparatus). A left intercostal thoracotomy was performed. The left anterior descending coronary artery was ligated with a 7-0 silk suture. After 30 min of ischemia, the occlusion was released and reperfusion was confirmed visually. Sham-operated mice underwent the same surgery minus the coronary artery ligation. The rectal temperatures of the mice were maintained at 37°C. Penicillin was used to prevent infection.
Reverse transcriptase polymerase chain reaction (RT-PCR) and Real-Time PCR analysis
PCR analysis was performed to determine the levels of iNOS in WT and eNOS -/-mouse non-ischemic hearts, using Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the cDNA quality and loading control. The primer sequences (sense/antisense) designed to detect mouse iNOS mRNA using Primer Express software (Applied Biosystems) were 5`-CTCTGACAGCCCAGAGTTCC-3` and 5`-GAAAGGGAGAGAGGGGAGG-3`. Triplicate heart specimens were frozen in liquid nitrogen and crushed. RNAs were extracted using TRIzol reagent (Invitrogen, Carlsbad, California). Isolated RNA (10 Mg) was reverse transcribed to first-strand cDNA using the Superscript II RT kit (Invitrogen, Carlsbad, California). PCR amplification was performed using 1 Ml cDNA in 1x Promega buffer, 0. 
Northern Blotting Analysis
Total RNA was extracted from homogenized tissue samples with Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Fifteen µg of isolated RNA was subjected to gel electrophoresis using 1% agrose gel containing 6% formaldehyde, and then transferred onto a nitrocellulose membrane. Blots were hybridized using a 32 P-labeled iNOS cDNA probe (Alpha Diagnostic, San Antonio, TX). For quantitative purposes, the blots were exposed to a phosphor-imaging screen and the exposed screens were analyzed in a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). Each signal was normalized to the 18S signal.
Western Blotting Analysis
Tissue samples were homogenized in 25 mM Tris buffer (pH 7.5) containing 0.5 mM EDTA/0.5 mM EGTA/1 mM PMSF/protease inhibitor cocktail, and then centrifuged at 14,000 g for 15 min. The resulting supernatants were collected as cytosolic fractions. The protein content of the supernatant was determined using the DC-protein assay (BioRad, Hercules, CA). The 
Immunohistochemistry for iNOS and Nitrotyrosine
For iNOS staining, paraformaldehyde-fixed, paraffin-embedded cardiac sections were incubated with purified rabbit anti-iNOS polyclonal antibody (1:200) overnight at 4 ºC and then reacted with biotin-conjugated secondary antibody and streptavidin-HRP conjugated solution.
Color was developed using diaminobenzidine (17) . For nitrotyrosine staining, mouse heart infused with peroxynitrite (1 mM, 0.05 ml, Cayman Chemical Co.) into the left ventricular chamber was taken as the positive control with the heart removed and fixed after 15 min.
Immunohistochemistry was performed by the method published previously by our laboratory (29) . Briefly, the formalin-fixed paraffin sections were incubated with rabbit polyclonal antinitrotyrosine antibody (1:100, Upstate, Charlottesville, VA) for one hour, then with the biotinylated secondary antibody, and again with the tertiary, ExtrAvidin alkaline phosphatase (Vector Laboratories, Burlingame, CA). Color was developed using fast red.
Myocardial Infarct Size Determination
Infarct size was measured in eNOS Forty eight hours after reperfusion, the mouse was re-intubated and ventilated as above, the left coronary artery was re-occluded, and 0.15 ml of 4.0% Evans blue (Sigma) was injected from the inferior vena cave to delineate the non-ischemic myocardial tissue. The heart was then cut into four transverse slices. The slices were stained with 1. 
Measurement of Hemodynamics
Forty eight hours after reperfusion, the right carotid artery was cannulated with a Millar tip transducer catheter (model SPR-261, 1.4F) connected to a PowerLab system. After arterial blood pressure and heart rate were obtained, the catheter was advanced to the LV for measurement of LV systolic and end-diastolic pressures (LVEDP) as well as the maximal rate of pressure development (+dP/dt) and rate of relaxation (-dP/dt) of LV. Rate pressure product was calculated by the equation: rate pressure product (mmHg/min) = mean arterial pressure × heart rate.
In Vivo EPR Oximetry
In vivo EPR oximetry was performed as we reported previously (35) . This technique has the unique capability of providing repeated noninvasive measurements of tissue PO 2 over long period of time up to several months (35) . The in vivo ischemia/reperfusion mouse model was produced as described above. After thoracotomy, about 10 µg of lithium octa-n-butoxynaphthalocyanine (LiNc-BuO) crystals was implanted into the myocardium at the center of the risk region using a 25-gauge needle. The mouse was then placed into the EPR system with a surface coil resonator placed on the left sternum just above the heart and the myocardial oxygenation was measured continuously. At 24 and 72 hours post reperfusion the mice were again anesthetized and EPR measurements performed. EPR measurements were performed with the use of a custom-made L-band spectrometer with a frequency of 1.1 GHz, microwave power 16 mW, modulation field 7×10 -6 T, scan width 5×10 -4 T (11, 12) . The implanted crystals were confirmed by histology to be located at the middle layer of the left ventricular myocardium.
Mitochondrial Enzyme Activity Assay
Forty eight hours after reperfusion, mouse hearts were excised and the myocardium in the risk region was immediately frozen with liquid nitrogen. The hearts from intact animals were taken as the baseline control. The tissues were homogenized in ice-cold Hepes buffer (3 mM, pH 
Statistical Analysis
Two-way ANOVA was used for analysis of the data with time-course followed by Newman-Keuls multiple-comparison test. T test was used for data comparison between WT and eNOS -/-mice. The data was represented as Mean ± SEM. A value of P less than 0.05 was considered as significant.
RESULTS iNOS mRNA and Protein Expression in Normal and Postischemic Myocardium
In normal control hearts not subjected to ischemia, iNOS mRNA expression measured by RT-PCR appeared to be a little bit lower in the eNOS that the copy number was quite low, ~0.1 % of the GAPDH copy number in the WT mice and eNOS-/-mice. Furthermore, there was no detectable iNOS protein on Western blotting in either strain of control nonischemic mice ( Figure 1D ). In the risk region of hearts subjected to 30 min of coronary ligation followed by 48 hrs of reperfusion, iNOS mRNA expression was readily detected in both eNOS -/-mice and WT mice, but these levels were lower in eNOS -/-mice than in WT ( Figure 1C) . Similarly, the levels of iNOS protein detected on immunoblotting were greatly increased in WT, but increased to a lesser extent in eNOS -/-heart tissue ( Figure 1D 
Nitrotryosine Staining as a Marker of Peroxynitrite Production
The positive control shown in Figure 3A was created by in vivo injection of a bolus of peroxynitrite into the LV chamber that results in a portion of it being infused into the coronary arteries. Because of this, the nitrotyrosine levels are higher in the capillaries than in the myocytes and one sees lines or patches of strong positive red staining in capillaries that were exposed to this peroxynitrite and formed high levels of nitrotyrosine. Based on the negative charge of peroxynitrite only low levels would reach the myocytes so that the staining in myocytes is much weaker than that see in the endothelium. In the myocardium of reperfused hearts (C) staining for nitrotyrosine is positive within myocytes and also in inflammatory cells. In postischemic myocardium of eNOS-/-hearts, the myocardium appears blue with little or very weak red staining, however, some positive red staining is seen in inflammatory cells. There was no staining in negative control ( Figure 3B ).
Myocardial Infarct Size
With 30 min of coronary ligation followed by 48 hrs of reperfusion, infarct size in eNOS 
Hemodynamics
In vivo hemodynamics was measured in mice 48 hr after reperfusion by left ventricular catheterization. eNOS -/-mice exhibited significantly higher MAP, LVSP, +dp/dt, -dp/dt and rate pressure product compared with WT mice (Table) .
In Vivo Myocardial Tissue PO 2
In vivo myocardial tissue PO 2 was monitored acutely and for 72 hrs by EPR oximetry. 
Enzymatic Activities of Mitochondrial Electron Transport Chain in Myocardium
Considering the dependence of cardiac function on bioenergetic metabolism and the regulation of iNOS-derived NO on mitochondrial respiration, the enzymatic activities of CcO and NADH-DH were assayed in postischemic myocardium. In WT and eNOS -/-mice, both myocardial CcO activity and NADH-DH activity were significantly decreased at 48 hrs after reperfusion in WT (P < 0.01) and eNOS -/-mice (P < 0.05 -0.01) compared to baseline control respectively. No significant difference was found for CcO activity between WT and eNOS -/-mice ( Figure 6, A) . However, NADH-DH activity was significantly higher 48 hrs after reperfusion in eNOS -/-mice than in WT mice (P<0.05) (Figure 6 , B).
Protein Expression of Mitochondrial Electron Transport Chain in Myocardium
To explore the regulatory mechanisms of mitochondrial respiration at the level of translation, protein expressions of CcO and NADH-DH were probed by Western blotting.
Protein expression of the CcO was mildly decreased in postischemic myocardium in WT and eNOS -/-mice compared to baseline control, and there was no significant difference between the two groups (Figure 7, A) . However, protein expression of the NADH-DH in postischemic myocardium was mildly but significantly lower in eNOS -/-mice compared to that in WT (n = 3, P < 0.05) (Figure 7, B) .
DISCUSSION
In this study, we have demonstrated that deficiency of eNOS exerted a beneficial effect on postischemic myocardium 48 hrs after reperfusion with decreased infarct size, improved cardiac function, and preserved mitochondrial function. This protection appears to be due to a decrease of iNOS induction and iNOS-derived NO and peroxynitrite in postischemic myocardium.
The induction of myocardial iNOS in the early postischemic phase in eNOS -/-mice has been reported in isolated hearts but remains controversial (17, 20) . Mild iNOS induction in eNOS -/-mice has been suggested to contribute to the protective effect at 60 min (17) or 24 hr reperfusion (24). It has been noted in failing hearts that because of the high NO output of iNOS, even modest expression of this enzyme might account for significant NO production (27).
However, it is also known that iNOS is prone to produce superoxide, with this occurring from the reductase site as well as the oxygenase site (32, 34) . Thus, iNOS can produce the potent oxidant peroxynitrite and this is favored by tetrahydrobiopterin consumption or L-arginine depletion (32) (33) (34) .
In this study, we have demonstrated that myocardial iNOS expression at both mRNA and protein levels were significantly lower in eNOS , and the pathophysiological response was markedly different. We hypothesize that this is due to the higher amount of NO and NO-derived peroxynitrite produced from iNOS in postischemic myocardium. With this higher level of iNOS induction, higher levels of the peroxynitrite product nitrotyrosine were seen in the postischemic myocardium of the WT mice. Interestingly, while nitrotyrosine staining was more prominent in WT, lower levels were still detectable in the eNOS -/-hearts. Since it has been shown that NOS-independent NO formation from nitrite can occur in ischemic myocardium, this lower level nitrotyrosine staining may arise in part from these NOSindependent pathways (41).
Lower amounts of NO production have been reported to be beneficial, but high amounts of NO harmful (16). Increased NO formation during ischemia or the early period of reperfusion has also been shown to occur in hearts subjected to global ischemia by our laboratory and others (40, 41). In general, it has been shown that during the acute process of myocardial ischemia and reperfusion that myocardial levels of NO and nitrosyl-heme proteins are greatly increased (26, 29) . The protection observed in this study appears to be partially induced by the abolishment of the acute increase in eNOS-derived NO. The balance between NO and free oxygen radicals is also crucial in modulating the outcome after an ischemic insult (29) . If NO is formed in the presence of superoxide, as occurs during the early period of reperfusion, it rapidly reacts to form the potent oxidant peroxynitrite, which oxidizes and nitrates proteins inducing cellular injury (1, 6, 30) . Higher NO concentrations (in the µM range) can also directly reduce cardiomyocyte function, mediate inflammatory processes following ischemia/reperfusion, impair mitochondrial respiration, and even induce cardiomyocyte death (21, 22).
In the present study, infarct size was found to be decreased in eNOS mice treated with 1400W could be due to a near total absence of NO production from both eNOS and iNOS in their study. While lower physiological levels of NO may be beneficial, pathologically increased NO could induce injury (21, 22). Another concern is that the total dose of 1400W used in their study is high and high doses of the drug can cause adverse hemodynamic effects (7) . Overall, our studies clearly suggest that the increased iNOS expression in the postischemic heart is involved in exacerbation of myocardial injury and that less iNOS induction results in less injury. At low levels of tissue oxygen tension, NO reversibly inhibits the respiratory chain because NO competes with O 2 in binding to CcO. The sensitivity of cellular respiration to NO depends on the O 2 concentration, substrate type, and respiration rate in rat heart mitochondria.
The effect of NO is more effective at low O 2 concentrations (19) . The NO-derived oxidant, peroxynitrite, can induce irreversible inhibition on many mitochondrial components, especially NADH-DH (28) . NO and its derivatives may contribute to left ventricular dysfunction by inhibition of CcO and NADH-DH in mitochondrial respiration and thus reduction of ATP synthesis (30) . Our previous study showed that CcO activity was not decreased or influenced by eNOS-derived NO in post ischemic myocardium at early times of reperfusion of 60 min (35) . 
